Age-modified factors associated with placental malaria in rural Burkina Faso.
Burkina Faso
Malaria
Placenta
Pregnancy
Risk factors
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
24 Mar 2022
24 Mar 2022
Historique:
received:
27
11
2020
accepted:
31
01
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Malaria in pregnancy can result in placental infection with fetal implications. This study aimed at assessing placental malaria (PM) prevalence and its associated factors in a cohort of pregnant women with peripheral malaria and their offspring. The data were collected in the framework of a clinical trial on treatments for malaria in pregnant women . Placental malaria (PM) was diagnosed by histopathological detection of parasites and/or malaria pigment on placenta biopsies taken at delivery. Factors associated with PM were assessed using logistic regression. Out of 745 biopsies examined, PM was diagnosed in 86.8 % of women. Acute, chronic and past PM were retrieved in 11 (1.5 %), 170 (22.8 %), and 466 (62.6 %) women, respectively. A modifying effect was observed in the association of gravidity or anemia at the study start with pooled PM (presence of parasites and/or malaria pigment). In women under 30, gravidity ≤ 2 was associated with an increased prevalence of pooled PM but in women aged 30 years or more, gravidity was no more associated with pooled PM (OR 6.81, 95 % CI 3.18 - 14.60; and OR 0.52, 95 % CI 0.10 - 2.76, respectively). Anemia was associated with pooled PM in women under 30 (OR 1.96, 95 % CI 1.03 - 3.72) but not in women aged 30 years or more (OR 0.68, 95 % CI 0.31 - 1.49). Similarly, the association of gravidity with past-chronic PM depended also on age. A higher prevalence of active PM was observed in women under 30 presenting with symptomatic malaria (OR 3.79, 95 % CI 1.55 - 9.27), while there was no significant increase in the prevalence of active PM (presence of parasites only) in women with symptomatic malaria when aged 30 years or more (OR 0.42, 95 % CI 0.10 - 1.75). In women with chronic PM, the prevalence of low birth weight or prematurity was the highest (31.2 %) as compared with past PM or no PM. Despite the rapid diagnosis and efficacious treatment of peripheral infection, the prevalence of placental malaria remained high in women with P. falciparum peripheral infection in Nanoro, especially in younger women This underlines the importance of preventive measures in this specific group.
Sections du résumé
BACKGROUND
BACKGROUND
Malaria in pregnancy can result in placental infection with fetal implications. This study aimed at assessing placental malaria (PM) prevalence and its associated factors in a cohort of pregnant women with peripheral malaria and their offspring.
METHOD
METHODS
The data were collected in the framework of a clinical trial on treatments for malaria in pregnant women . Placental malaria (PM) was diagnosed by histopathological detection of parasites and/or malaria pigment on placenta biopsies taken at delivery. Factors associated with PM were assessed using logistic regression.
RESULTS
RESULTS
Out of 745 biopsies examined, PM was diagnosed in 86.8 % of women. Acute, chronic and past PM were retrieved in 11 (1.5 %), 170 (22.8 %), and 466 (62.6 %) women, respectively. A modifying effect was observed in the association of gravidity or anemia at the study start with pooled PM (presence of parasites and/or malaria pigment). In women under 30, gravidity ≤ 2 was associated with an increased prevalence of pooled PM but in women aged 30 years or more, gravidity was no more associated with pooled PM (OR 6.81, 95 % CI 3.18 - 14.60; and OR 0.52, 95 % CI 0.10 - 2.76, respectively). Anemia was associated with pooled PM in women under 30 (OR 1.96, 95 % CI 1.03 - 3.72) but not in women aged 30 years or more (OR 0.68, 95 % CI 0.31 - 1.49). Similarly, the association of gravidity with past-chronic PM depended also on age. A higher prevalence of active PM was observed in women under 30 presenting with symptomatic malaria (OR 3.79, 95 % CI 1.55 - 9.27), while there was no significant increase in the prevalence of active PM (presence of parasites only) in women with symptomatic malaria when aged 30 years or more (OR 0.42, 95 % CI 0.10 - 1.75). In women with chronic PM, the prevalence of low birth weight or prematurity was the highest (31.2 %) as compared with past PM or no PM.
CONCLUSION
CONCLUSIONS
Despite the rapid diagnosis and efficacious treatment of peripheral infection, the prevalence of placental malaria remained high in women with P. falciparum peripheral infection in Nanoro, especially in younger women This underlines the importance of preventive measures in this specific group.
Identifiants
pubmed: 35331181
doi: 10.1186/s12884-022-04568-4
pii: 10.1186/s12884-022-04568-4
pmc: PMC8951713
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
248Subventions
Organisme : Medical Research Council
ID : MC_UU_00026/1
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
J Nutr. 2001 Feb;131(2S-2):604S-614S; discussion 614S-615S
pubmed: 11160593
Curr Mol Med. 2006 Mar;6(2):269-73
pubmed: 16515517
Reprod Health. 2015 Jan 15;12:5
pubmed: 25592254
Lancet Glob Health. 2014 Aug;2(8):e460-7
pubmed: 25103519
PLoS One. 2017 Jul 28;12(7):e0182394
pubmed: 28753649
Malar J. 2018 Oct 16;17(1):364
pubmed: 30326904
Trans R Soc Trop Med Hyg. 2002 Nov-Dec;96(6):644-6
pubmed: 12625141
Afr Health Sci. 2015 Sep;15(3):810-8
pubmed: 26957969
Malar J. 2019 Dec 10;18(1):412
pubmed: 31823793
Placenta. 2004 May;25(5):359-78
pubmed: 15081631
Am J Trop Med Hyg. 2018 Feb;98(2):534-542
pubmed: 29210351
Ann Trop Med Parasitol. 1997 Oct;91(7):803-10
pubmed: 9625937
N Engl J Med. 2016 Mar 10;374(10):928-39
pubmed: 26962728
Hum Pathol. 2000 Jan;31(1):85-93
pubmed: 10665918
Birth Defects Res. 2019 Jun 1;111(10):569-583
pubmed: 30919596
Malar J. 2017 Sep 16;16(1):374
pubmed: 28915896
Malar J. 2020 Jun 24;19(1):227
pubmed: 32580739
BMJ Open. 2018 Jan 8;8(1):e019014
pubmed: 29317419
Int J Gynaecol Obstet. 2016 Sep;134(3):309-14
pubmed: 27365291
Hematology Am Soc Hematol Educ Program. 2009;:87-93
pubmed: 20008186
Int J Infect Dis. 2019 Jul;84:54-65
pubmed: 31028878
Am J Trop Med Hyg. 2013 Jun;88(6):1093-101
pubmed: 23546807
Malar J. 2017 Oct 5;16(1):400
pubmed: 28982374
J Infect Dis. 2019 Jul 2;220(3):457-466
pubmed: 30891605
BMC Pregnancy Childbirth. 2015 Aug 21;15:183
pubmed: 26292718
BMC Med. 2016 Sep 19;14(1):142
pubmed: 27645498
PLoS One. 2013 Jun 06;8(6):e65876
pubmed: 23762446
Malar J. 2013 Apr 24;12:139
pubmed: 23617626
Nat Commun. 2013;4:1609
pubmed: 23511473
Matern Child Nutr. 2019 Jul;15(3):e12751
pubmed: 30426676
Malar J. 2019 May 6;18(1):161
pubmed: 31060615
PLoS One. 2013 Sep 18;8(9):e74643
pubmed: 24058614
Lancet Infect Dis. 2007 Feb;7(2):93-104
pubmed: 17251080
Lancet. 2013 Aug 3;382(9890):427-451
pubmed: 23746772
PLoS Med. 2017 Feb 28;14(2):e1002243
pubmed: 28245259
Parasitology. 2007;134(Pt 13):1883-93
pubmed: 17958924
Malar J. 2017 Jan 23;16(1):38
pubmed: 28114990
J Infect Dis. 2018 Aug 24;218(7):1099-1109
pubmed: 29733403
PLoS Pathog. 2016 Aug 24;12(8):e1005831
pubmed: 27556547
Malar J. 2019 Apr 23;18(1):144
pubmed: 31014336
Clin Microbiol Rev. 2009 Jan;22(1):13-36, Table of Contents
pubmed: 19136431
Malar J. 2015 May 26;14:215
pubmed: 26006260
Lancet Infect Dis. 2018 Apr;18(4):e107-e118
pubmed: 29396010
Clin Infect Dis. 2019 Feb 1;68(4):586-596
pubmed: 29961848
Malar J. 2012 May 03;11:150
pubmed: 22554092
Malar J. 2017 Oct 24;16(1):427
pubmed: 29065884
Parasitology. 2007;134(Pt 13):1877-81
pubmed: 17958923
J Infect Dis. 2010 Nov 15;202(10):1608-16
pubmed: 20929353
J Infect Dis. 2017 Sep 15;216(6):732-735
pubmed: 28934438
Trials. 2020 Jul 2;21(1):607
pubmed: 32616063
BMC Infect Dis. 2020 Aug 5;20(1):573
pubmed: 32758164
Am J Trop Med Hyg. 2004 Apr;70(4):398-407
pubmed: 15100454
Trends Parasitol. 2016 Apr;32(4):296-308
pubmed: 26708404
BMC Med. 2015 Sep 07;13:212
pubmed: 26343145
BMC Public Health. 2019 Oct 26;19(1):1379
pubmed: 31655557
PLoS One. 2015 Sep 14;10(9):e0137440
pubmed: 26368675
N Engl J Med. 2016 Mar 10;374(10):913-27
pubmed: 26962727
J Nutr. 2015 May;145(5):1039S-1108S
pubmed: 25833893
BMC Med. 2020 Jun 2;18(1):138
pubmed: 32482173
PLoS One. 2015 Aug 10;10(8):e0132247
pubmed: 26258474
Trends Parasitol. 2011 Apr;27(4):168-75
pubmed: 21377424
Malar J. 2013 Dec 27;12:464
pubmed: 24373481
Science. 2012 Feb 24;335(6071):936-41
pubmed: 22363001
JAMA. 2012 May 16;307(19):2079-86
pubmed: 22665107
Trans R Soc Trop Med Hyg. 2015 May;109(5):313-24
pubmed: 25758854
mBio. 2018 May 8;9(3):
pubmed: 29739900
Malar J. 2009 Jan 23;8:19
pubmed: 19166589
Malar J. 2014 Jun 13;13:232
pubmed: 24927762
Int J Infect Dis. 2012 Dec;16(12):e860-5
pubmed: 22951427
Clin Infect Dis. 2008 May 15;46(10):1582-8
pubmed: 18419494
Cold Spring Harb Perspect Med. 2017 Jun 1;7(6):
pubmed: 28213434